| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919640 | Radiotherapy and Oncology | 2011 | 5 Pages |
Abstract
In most patients CE is not required to visualize a known breast tumor. Mammographic visibility is a good parameter to decide on the use of CE.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Liesbeth J. Boersma, Bianca Hanbeukers, Carla Boetes, Jacques Borger, Piet van den Ende, Els van Haaren, Ruud Houben, Jos Jager, Lars Murrer, Suprapto Sastrowijoto, Angela van Baardwijk,